Sun 29 Nov 2009 | 10:30 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Novogen Ltd

Novogen Ltd (NVGN.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View NVGN on other exchanges
As of  27 Nov 2009
2.26USD
Price Change
+0.04
Percent Change
+1.87%
 
Research Another Stock: Symbol Look-up

Name Total Annual Compensation Long-Term Incentive Plans All Other Fiscal Year Total
As Of 29 Jun 2009
Erratt, Ronald 105,049 -- 138,350 243,399
Husband, Alan 320,533 -- 158,011 478,544
Johnston, Philip 105,319 -- 90,458 195,777
Kearney, Craig 216,430 -- 60,380 276,810
Lancaster, Warren 257,195 -- 32,350 289,545
Leppinus, Geoffrey -- -- -- --
Naughton, Christopher 761,355 -- 173,708 935,063
Nestel, Paul -- -- -- --
Palmer, Bryan 219,220 -- 54,614 273,834
Rueckert, William -- -- -- --
Seaton, David 414,614 -- 176,546 591,160